KOSDAQ large cap
Hyundai Bioscience
A biotech developing antivirals and other drugs based on drug-delivery technology. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
048410.KQ Updated Jul 11, 2026 2 AI consumers· 2 recurring
Annual return · 2026-07-10'21+27.9%'22-17.9%'23+3.3%'24-40.6%'25+63%YTD-35.5%
Money in ▸·
Hyundai Bioscience
▸ Money out·
Financials & Segments
- Segments · Antiviral drug (Xafty) · Drug delivery and cosmetic materials
Revenue from
No refined links yet.
Pays to
No refined links yet.